Read More

The plant Vernonia cinerea of the family Asteraceae is widely distributed in the most tropical and subtropical part of the India. It is commonly known as ‘Sahadevi’. According to Ayurvedic pharmacopoeia of India it is recommended for the intermittent fever, blisters, pain, diuresis, various gastro-intestinal disorder, boils, malaria, vaginal discharge and in case of psychoneurosis. Therefore, the present study was designed to evaluate the antimicrobial activity as well as to describe the presence of phytoconstituents through phytochemical screening of the hydro-alcoholic extract of the whole parts of the plant. We carried out the phytochemical screening of the Vernonia cinerea which shows the presence of carbohydrate, reducing and non reducing sugar, glycoside, phytosterol & terpenoids, phenolic compound & tannin, flavonoids. Antimicrobial activity of the Vernonia cinerea against most dominating microbes like Staphylococcus aureus, Escherichia coli, Proteus mirabilis, Candida Spp. (albicans) through well diffusion method. The hydro alcoholic extract at various concentrations produces significant antimicrobial and antifungal activity against the selected microorganism when compared with standard drug Norfloxacin for antibacterial and antifungal activity.

Read More

Sustained-release and immediate-release tablets of Emblica officinalis have been developed to provide a controlled release of the active ingredients over an extended period of time. The sustained-release tablets are designed to release the active ingredients gradually, ensuring a consistent level of the compound in the bloodstream over several hours. The immediate-release tablets, on the other hand, release the active ingredients quickly, providing a rapid onset of action. The abstract of a study on sustained and immediate-release tablets of Emblica officinalis would summarize the research findings, including the method of preparation, the physicochemical properties of the tablets, and the in vitro and in vivo release characteristics. It may also include information on the pharmacokinetic profile of the tablets, their safety and tolerability, and their potential therapeutic applications.

Read More

Process analytical technology has emerged as a possible game-changing platform in the pharmaceutical business to improve process knowledge while also improving product quality and lowering production costs. This paper outlines the underlying principles of PAT, its application in pharmaceutical manufacturing processes, and the impact on assurance of quality and reduction of cost. Real-time monitoring, multivariate data analysis, and process control strategies are three modules that are computed and integrated with PAT to develop robust and efficient manufacturing processes. A number of case studies and examples have been used to illustrate this relationship between the implementation of PAT and a reduction in variability with an improvement in process control and consistency of the product, which finally realizes million-dollar savings. It also debates the regulatory perspectives and challenges involved in PAT adoption, focusing on how stakeholders in the industry and agencies can integrate in developing and implementing innovations that will pass the test of compliance criteria. In general, what this paper presents is that PAT will drive pharmaceutical manufacturing into advancement for higher standards of quality with increased efficiency.

Read More